Counterforce Health (Page 37)

More issues

Coding That Helps Get Orkambi (Lumacaftor/Ivacaftor) Approved by UnitedHealthcare in Florida: ICD-10, HCPCS, and NDC Requirements

Answer Box: Quick Path to Orkambi Coverage Getting Orkambi (lumacaftor/ivacaftor) covered by UnitedHealthcare in Florida requires specific coding and documentation. Use ICD-10 code E84.0-E84.9 for cystic fibrosis manifestations, submit genetic testing confirming F508del homozygous status, and ensure a CF specialist prescribes the medication. Submit prior authorization through

How to Get Humate-P Covered by Cigna in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Fast Track to Approval Humate-P requires prior authorization from Cigna in Illinois. Submit the Hemophilia Factor VIII Prior Authorization Form through CoverMyMeds or fax to Accredo at 855-840-1678. Include: diagnosis confirmation, von Willebrand disease subtype documentation, and proof of desmopressin trial/failure (unless contraindicated for your VWD type)

How to Get Elelyso (taliglucerase alfa) Covered by Cigna in Florida: Complete Guide to Forms, Appeals & Approval

Answer Box: Getting Elelyso Covered by Cigna in Florida Fastest path to approval: Submit prior authorization through CoverMyMeds or ExpressPAth with confirmed Type 1 Gaucher disease diagnosis, specialist prescriber, and documentation of medical necessity. If denied, file internal appeal within 180 days, then external review through Florida Department of Financial

Renewing Fabrazyme (Agalsidase Beta) Approval with UnitedHealthcare in Michigan: 2025 Requirements and Timeline

Answer Box: Renewing Fabrazyme with UnitedHealthcare in Michigan Fabrazyme requires annual reauthorization with UnitedHealthcare, typically 12 months after initial approval. Start the renewal process 30 days before expiration to avoid coverage gaps. Submit updated clinical documentation showing treatment response through your provider's UnitedHealthcare portal or OptumRx system. If

Renewing Vimizim (Elosulfase Alfa) Approval with Blue Cross Blue Shield of Texas: 2025 Requirements & Timeline

Answer Box: Vimizim Renewal with Blue Cross Blue Shield of Texas Good news for HealthSelect members: As of September 2024, Blue Cross Blue Shield of Texas HealthSelect plans no longer require prior authorization for Vimizim (elosulfase alfa) renewals. However, you still need an in-network PCP referral on file. For other

UnitedHealthcare's Coverage Criteria for Gattex (Teduglutide) in Pennsylvania: What Counts as "Medically Necessary"?

Answer Box: Getting Gattex Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Gattex (teduglutide) with strict medical necessity criteria: documented short bowel syndrome, 12+ months of parenteral nutrition dependence (≥3 days/week), failed enteral optimization attempts, and recent colonoscopy with polyp removal. Fastest path to approval: Submit complete

How Long Does It Take to Get Arcalyst (Rilonacept) Approved by UnitedHealthcare in Ohio? Complete Timeline Guide

Answer Box: Arcalyst Approval Timeline in Ohio UnitedHealthcare typically takes 5-15 business days to approve Arcalyst (rilonacept) after complete documentation is submitted. For recurrent pericarditis, you must first document failure of NSAIDs and colchicine. Expedited reviews are available within 72 hours for urgent cases. If denied, Ohio residents have 180

How to Get Elelyso (taliglucerase alfa) Covered by Aetna CVS Health in Virginia: Complete Guide with Forms and Appeal Process

Quick Answer: Getting Elelyso Covered by Aetna CVS Health in Virginia Elelyso (taliglucerase alfa) requires prior authorization from Aetna CVS Health in Virginia and is typically not on standard formularies. Here's your fastest path to approval: 1. Confirm diagnosis with enzyme deficiency or genetic testing results 2. Submit

How to Get Cystadane (Betaine Anhydrous) Covered by Cigna in Washington: Appeals Guide and Templates

Quick Answer: Getting Cystadane Covered by Cigna in Washington Cigna requires prior authorization for Cystadane (betaine anhydrous) with genetic/biochemical confirmation of homocystinuria due to CBS, MTHFR, or related enzyme deficiencies. If denied, Washington residents have strong appeal rights including internal appeals (180-day window) and binding external review by an

Get Xospata (Gilteritinib) Covered by Cigna in Texas: Complete Guide to Prior Authorization and Appeals

Answer Box: Your Path to Xospata Coverage Cigna requires prior authorization for Xospata (gilteritinib) in Texas. To get approved: (1) Ensure you have relapsed/refractory AML with documented FLT3 mutation via FDA-approved test, (2) Have your hematologist/oncologist submit prior authorization with complete treatment history, and (3) If denied, file